Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status

Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status

Abstract Background Intravenous iron replacement is recommended for iron-deficient patients with inflammatory bowel disease (IBD), but may be associated with hypophosphataemia, predisposing to osteomalacia and fractures. This study aimed to evaluate the incidence and risk factors for hypophosphataem...

Full description

Bibliographic Details
Main Authors: Wendy Fang, Rachel Kenny, Qurat-ul-Ain Rizvi, Lawrence P. McMahon, Mayur Garg
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Gastroenterology
Subjects:
Iron deficiency
Ferric carboxymaltose
Inflammatory bowel disease
Hypophosphataemia
Vitamin D
Online Access:http://link.springer.com/article/10.1186/s12876-020-01298-9

Similar Items

Similar Items